Wednesday, December 03, 2014 10:30:55 AM
Not about the subject of the post:
"RIGH Convertible Debt buys Genius Biotech shares!"
That is completely true.
Where I was wrong was in stating that
In fact, that debt was taken on on February 24, 2014, not in the last Quarter.
My sincere apologies for the mis-statement.
My concerns about the conversion of that debt into an unspecified number of shares of Genius Biotech promised to an unnamed "third party" remain as stated.
Converting debt into an unnamed number of shares of a company that has not even yet been listed (Genius Biotech) should be a major concern for shareholders or would-be investors.
The company has not yet even been listed, and common shareholders have been diluted. By how much, they have no way of knowing.
The caveat stands:
SEE:
"Death Spiral Financing" and "Funding Commitments"...
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108323451
And:
"Toxic Financing". Why $RIGH is a "failed business"...
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108275566
Best to all of honest intentions...
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM